Condition: Epithelial Ovarian Cancer · Peritoneal Cancer · Fallopian Tube Cancer · Sponsor: ARCAGY/ GINECO GROUP
This is a prospective observational French multicenter cohort in patients with ovarian and/or primitive peritoneal and/or fallopian tubes carcinoma, histologically confirmed, with an advanced stage at diagnosis (stage III to IV FIGO 2014). The objective is to constitute a clinico-biological database that allows to correlate clinical and progressive features of ovarian cancer patients based on tumor genomics and molecular detected abnormalities.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Centre de Radiothérapie et d'Oncologie de Moyenne Garonne (CROMG) | Agen, France | — |
| Hôpital Privé d'Aix en Provence | Aix-en-Provence, France | — |
| Centre Hospitalier Général d'Aix-en-Provence | Aix-en-Provence, France | — |
| CHU Amiens | Amiens, France | — |
| Clinique Victor PAUCHET | Amiens, France | — |
| Institut de Cancérologie de l'Ouest - ICO | Angers, France | — |
| Hôpital Privé d'Antony - Ramsay Santé | Antony, France | — |
| CH Arras | Arras, France | — |
| CH Auxerre | Auxerre, France | — |
| Institut Sainte Catherine | Avignon, France | — |
| Clinique Belharra | Bayonne, France | — |
| CH Côte Basque | Bayonne, France | — |
+ 125 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.